Indication
Rhegmatogenous Retinal Detachment
4 clinical trials
5 products
Product
ONL1204Product
Sham treatmentClinical trial
A Phase 2, Randomized, Sham-Controlled, Single-Masked, Dose-Ranging, Multi-Center Study to Assess the Safety and Efficacy of Intravitreal ONL1204 Ophthalmic Solution in Subjects With Macula-off Rhegmatogenous Retinal DetachmentStatus: Completed, Estimated PCD: 2024-02-21
Clinical trial
A Phase 1 Open-Label, Dose Escalation Study to Assess the Safety and Tolerability of Intravitreal ONL1204 in Patients With Macula-off, Rhegmatogenous Retinal DetachmentStatus: Completed, Estimated PCD: 2021-08-24
Clinical trial
The Evaluation of the Safety and Efficacy of Sustained Release Dexamethasone Intracanalicular Insert (DEXTENZA) in Pediatric Patients Following Retinal Surgery or Laser Treatment Under Anesthesia (TENDER)Status: Recruiting, Estimated PCD: 2024-04-01
Product
DextenzaProduct
Pred ForteClinical trial
Study of Vitreoretinal Molecular Changes During Rhegmatogenous Retinal DetachmentStatus: Recruiting, Estimated PCD: 2025-10-01
Product
Blood sampling